| Bioactivity | Dabuzalgron (Ro 115-1240) hydrochloride is an orally active and selective α-1A adrenergic receptor agonist for the treatment of urinary incontinence. Dabuzalgron hydrochloride protects against Doxorubicin-induced cardiotoxicity by preserving mitochondrial function[1]. |
| CAS | 219311-43-0 |
| Formula | C12H17Cl2N3O3S |
| Molar Mass | 354.25 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Beak J, et al. An Oral Selective Alpha-1A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity. JACC Basic Transl Sci. 2017 Feb;2(1):39-53. |
Dabuzalgron hydrochloride
CAS: 219311-43-0 F: C12H17Cl2N3O3S W: 354.25
Dabuzalgron (Ro 115-1240) hydrochloride is an orally active and selective α-1A adrenergic receptor agonist for the trea
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.